Vivek Subbiah, MD
@viveksubbiah
Chief, Early-Phase Drug Development|@SarahCannonDocs
#Oncologist, #Phase1trials, #PrecisionMedicine. Tweets=My own.
ID: 3085571050
http://rb.gy/2h7jj 11-03-2015 03:24:25
28,28K Tweet
35,35K Followers
2,2K Following
⭐️Nice editorial on “Neoadjuvant Immunotherapy in Breast Cancer - from #ClinicalTrials to #Practice” Dr. E Mittendorf Sara Tolaney JAMA Oncology JAMA jamanetwork.com/journals/jamao…